Stockreport

Novo Nordisk: Pfizer weight loss drug offers credible new competition [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Citi has reiterated its 'neutral' stance on Novo Nordisk (NYSE:NVO) , warning that competition in the obesity drug market continues to intensify following promising pha [Read more]